Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,989.35
-11.40 (-0.57%)
At close: Jul 31, 2026

BOM:524715 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-97,705102,68892,85746,23745,083
Short-Term Investments
-44,33050,96653,71260,04144,695
Trading Asset Securities
-193,131107,57344,33245,02236,771
Cash & Short-Term Investments
335,166335,166261,227190,901151,300126,548
Cash Growth
28.30%28.30%36.84%26.17%19.56%32.33%
Accounts Receivable
-155,097130,610112,602114,568105,035
Other Receivables
-3,6644,9136,1884,1363,509
Receivables
-159,288136,007119,440119,117110,243
Inventory
-120,585107,593102,949109,68392,392
Prepaid Expenses
-4,5893,7504,1353,7182,862
Other Current Assets
-19,28417,66717,32515,01516,601
Total Current Assets
-638,912526,245434,750398,833348,646
Property, Plant & Equipment
-124,948112,703113,001113,537111,689
Long-Term Investments
-37,89146,97764,41254,51749,592
Goodwill
-98,33189,39485,69083,58065,913
Other Intangible Assets
-135,46290,20587,33093,26861,918
Long-Term Accounts Receivable
----108.3193.7
Long-Term Deferred Tax Assets
-40,46544,07641,03735,18928,496
Other Long-Term Assets
-11,82711,37828,76928,39631,623
Total Assets
-1,087,852921,006854,997807,436698,078

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-73,33861,84356,53356,81544,898
Accrued Expenses
-25,24218,85616,88915,12714,833
Short-Term Debt
-40,50418,67128,44459,5834,685
Current Portion of Long-Term Debt
----2,3962,323
Current Portion of Leases
-1,8411,3681,2571,2811,078
Current Income Taxes Payable
-13,5007,3324,1173,0871,756
Current Unearned Revenue
-2,9571,3441,2651,5671,930
Other Current Liabilities
-68,83972,52861,33959,214100,582
Total Current Liabilities
-226,220181,942169,844199,070172,085
Long-Term Debt
-312.625.213.3-2,299
Long-Term Leases
-3,6163,5573,0235,5992,518
Long-Term Unearned Revenue
-3,4803,7674,8875,6996,188
Pension & Post-Retirement Benefits
-5,0274,5353,9973,2623,434
Long-Term Deferred Tax Liabilities
-3,7801,9241,719316.9318.6
Other Long-Term Liabilities
-6,618395.2253.7334.6575.4
Total Liabilities
-249,055196,146183,737214,281187,417

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-2,3992,3992,3992,3992,399
Additional Paid-In Capital
-11,87411,87411,87411,87411,874
Retained Earnings
-694,677614,525537,452472,009412,363
Comprehensive Income & Other
-126,75193,38284,94273,67153,476
Total Common Equity
835,701835,701722,180636,668559,954480,112
Minority Interest
-3,0972,67934,59233,20130,549
Shareholders' Equity
838,797838,797724,860671,259593,155510,661
Total Liabilities & Equity
-1,087,852921,006854,997807,436698,078

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
46,27346,27323,62232,73768,85912,903
Net Cash (Debt)
288,893288,893237,605158,16482,441113,645
Net Cash Growth
21.58%21.58%50.23%91.85%-27.46%99.57%
Net Cash Per Share
120.48120.4199.0365.9234.3647.37
Filing Date Shares Outstanding
2,3922,3992,3992,3992,3992,399
Total Common Shares Outstanding
2,3922,3992,3992,3992,3992,399
Working Capital
-412,692344,303264,906199,763176,562
Book Value Per Share
348.31348.31300.99265.35233.38200.10
Tangible Book Value
601,909601,909542,581463,648383,105352,282
Tangible Book Value Per Share
250.86250.86226.14193.24159.67146.82
Land
-8,2667,8568,1736,6766,448
Buildings
-74,41565,32563,61061,39557,836
Machinery
-169,555152,025146,265139,645132,031
Construction In Progress
-13,80712,34311,0779,6347,975